Visit Community Pharmacy England website

Community Pharmacy England
  • About Us
    • Constitution
    • Contact Us
    • Terms of Reference
  • Board Meetings & Events
    • CP London Board Meetings
    • Events
  • Newsletters
  • NHS Contract
  • Resources
    • Core Hours Check Toolkit
    • Locally Commissioned Services
    • PL Members Area
  • Training
  • About Us
    • Back to Main Menu
    • About Us
    • Constitution
    • Contact Us
    • Terms of Reference
  • Board Meetings & Events
    • Back to Main Menu
    • Board Meetings & Events
    • CP London Board Meetings
    • Events
  • Newsletters
  • NHS Contract
  • Resources
    • Back to Main Menu
    • Resources
    • Core Hours Check Toolkit
    • Locally Commissioned Services
    • PL Members Area
  • Training

Welcome to the website of Community Pharmacy London

The objective of Community Pharmacy London is to support and represent member LPCs in addressing London-wide issues affecting Community Pharmacy. CPL represents 8 LPCs which represent nearly 1500 community pharmacies in London

CONTACT US >>>

  • CONOR PRICE - CEO - conor.price@nhs.net
  • RAJ MATHARU - CHAIR - lpc@communitypharmacysel.org

LATEST CP LONDON NEWS

CP x GP SUMMIT - 12 NOVEMBER 2025

CP LONDON BUSINESS PLAN 2025/26

Latest Community Pharmacy England News

Visit Community Pharmacy England's website

NMS myth busting series (#1)

   

12th May 2026

We’re coming to a town near you

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the…

11th May 2026

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has…

11th May 2026

IT system selection survey

NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system…

11th May 2026

MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings

The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise…

11th May 2026

Expressions of interest open for East and North Midlands Representative

Eligible pharmacists in the East and North Midlands have been invited to express interest in joining Community Pharmacy England’s Committee. Expressions of Interest are now…

8th May 2026

© Copyright 2026 Community Pharmacy London • Site designed and built by Make Agency